Common variants in or near ZNRF1, COLEC12, SCYL1BP1 and API5 are associated with diabetic retinopathy in Chinese patients with type 2 diabetes

Diabetologia

Volumn 58, Issue 6, 2015, Pages 1231-1238

  Peng, Danfeng ^a   Wang, Jie ^a   Zhang, Rong ^a   Jiang, Feng ^a   Tang, Shanshan ^a   Chen, Miao ^a   Yan, Jing ^a   Sun, Xue ^a   Wang, Shiyun ^a   Wang, Tao ^a   Yan, Dandan ^a   Bao, Yuqian ^a   Hu, Cheng ^a   Jia, Weiping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Diabetic retinopathy; Polymorphisms; Type 2 diabetes

Indexed keywords

API5 PROTEIN, HUMAN; APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; COLEC12 PROTEIN, HUMAN; COLLECTIN; NUCLEAR PROTEIN; SCAVENGER RECEPTOR; SCYL1BP1 PROTEIN, HUMAN; ZNRF1 PROTEIN, HUMAN;

AGED; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DIABETIC RETINOPATHY; ETHNOLOGY; EYE FUNDUS; FEMALE; GENETIC ASSOCIATION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITY CONTROL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; APOPTOSIS REGULATORY PROTEINS; ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; CHINA; COLLECTINS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FUNDUS OCULI; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUALITY CONTROL; RECEPTORS, SCAVENGER;

EID: 84937762774     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3569-9     Document Type: Article

References (34)

1. Klein BE (2007) Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 14:179–183
2. Yau JW, Rogers SL, Kawasaki R et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556–564
3. Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412
4. Tapp RJ, Shaw JE, Harper CA et al (2003) The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 26:1731–1737
5. Zhang X, Saaddine JB, Chou CF et al (2010) Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 304:649–656
6. Sun JK, Keenan HA, Cavallerano JD et al (2011) Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the Joslin 50-Year Medalist Study. Diabetes Care 34:968–974
7. Liew G, Klein R, Wong TY (2009) The role of genetics in susceptibility to diabetic retinopathy. Int Ophthalmol Clin 49:35–52
8. Leslie RD, Pyke DA (1982) Diabetic retinopathy in identical twins. Diabetes 31:19–21
9. The Diabetes Control and Complications Trial Research Group (1997) Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 46:1829–1839
10. Zhang X, Gao Y, Zhou Z, Wang J, Zhou Q, Li Q (2010) Familial clustering of diabetic retinopathy in Chongqing, China, type 2 diabetic patients. Eur J Ophthalmol 20:911–918
11. Rema M, Saravanan G, Deepa R, Mohan V (2002) Familial clustering of diabetic retinopathy in South Indian type 2 diabetic patients. Diabet Med 19:910–916
12. Looker HC, Nelson RG, Chew E et al (2007) Genome-wide linkage analyses to identify Loci for diabetic retinopathy. Diabetes 56:1160–1166
13. Hietala K, Forsblom C, Summanen P, Groop PH (2008) Heritability of proliferative diabetic retinopathy. Diabetes 57:2176–2180
14. Arar NH, Freedman BI, Adler SG et al (2008) Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci 49:3839–3845
15. Ng DP (2010) Human genetics of diabetic retinopathy: current perspectives. J Ophthalmol 2010:172593
16. Fu YP, Hallman DM, Gonzalez VH et al (2010) Identification of diabetic retinopathy genes through a genome-wide association study among Mexican-Americans from Starr County, Texas. J Ophthalmol 2010:861291
17. Grassi MA, Tikhomirov A, Ramalingam S, Below JE, Cox NJ, Nicolae DL (2011) Genome-wide meta-analysis for severe diabetic retinopathy. Hum Mol Genet 20:2472–2481
18. Grassi MA, Tikhomirov A, Ramalingam S et al (2012) Replication analysis for severe diabetic retinopathy. Invest Ophthalmol Vis Sci 53:2377–2381
19. Jia W, Gao X, Pang C et al (2009) Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS). Nephrol Dial Transplant 24:3724–3731
20. Hu C, Zhang R, Wang C et al (2010) Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion. PLoS One 5:e11761
21. Hu C, Wang C, Zhang R et al (2010) Association of genetic variants of NOS1AP with type 2 diabetes in a Chinese population. Diabetologia 53:290–298
22. Wilkinson CP, Ferris FL 3rd, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682
23. Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 81:559–575
24. Hindorff LA, Sethupathy P, Junkins HA et al (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106:9362–9367
25. Yoshida K, Watanabe M, Hatakeyama S (2009) ZNRF1 interacts with tubulin and regulates cell morphogenesis. Biochem Biophys Res Commun 389:506–511
26. Wakatsuki S, Saitoh F, Araki T (2011) ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3B-dependent CRMP2 phosphorylation. Nat Cell Biol 13:1415–1423
27. Hoxhaj G, Najafov A, Toth R, Campbell DG, Prescott AR, MacKintosh C (2012) ZNRF2 is released from membranes by growth factors and, together with ZNRF1, regulates the Na+/K+ATPase. J Cell Sci 125:4662–4675
28. Nakamura K, Funakoshi H, Miyamoto K, Tokunaga F, Nakamura T (2001) Molecular cloning and functional characterization of a human scavenger receptor with C-type lectin (SRCL), a novel member of a scavenger receptor family. Biochem Biophys Res Commun 280:1028–1035
29. Jang S, Ohtani K, Fukuoh A et al (2009) Scavenger receptor collectin placenta 1 (CL-P1) predominantly mediates zymosan phagocytosis by human vascular endothelial cells. J Biol Chem 284:3956–3965
30. Yan J, Di Y, Shi H, Rao H, Huo K (2010) Overexpression of SCYL1-BP1 stabilizes functional p53 by suppressing MDM2-mediated ubiquitination. FEBS Lett 584:4319–4324
31. Hu L, Liu M, Chen L et al (2012) SCYL1 binding protein 1 promotes the ubiquitin-dependent degradation of Pirh2 and has tumor-suppressive function in the development of hepatocellular carcinoma. Carcinogenesis 33:1581–1588
32. Yang ZP, Xie YH, Ling DY et al (2014) SCYL1BP1 has tumor-suppressive functions in human lung squamous carcinoma cells by regulating degradation of MDM2. Asian Pac J Cancer Prev 15:7467–7471
33. Morris EJ, Michaud WA, Ji JY, Moon NS, Rocco JW, Dyson NJ (2006) Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo. PLoS Genet 2:e196
34. Cho H, Chung JY, Song KH et al (2014) Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer. BMC Cancer 14:545